Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nihon KohdenNHNKY -0.40%73 EV-to-OCF is 9.58 as of Sep. 17, 2026, which is 47% below its 10-year median of 18.18. GuruFocus rates NHNKY with a GF Score™ of 73/100 and a GF Value™ of $12.71 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Nihon Kohden ranks worse than 53.29% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Nihon Kohden's Enterprise Value is $1,426 Mil.
Nihon Kohden's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $149 Mil. Therefore, Nihon Kohden's EV-to-OCF for today is 9.58.
The historical rank and industry rank for Nihon Kohden's EV-to-OCF or its related term are showing as below:
NHNKY'
s EV-to-OCF Range Over the Past 10 Years
Min: -113.61 Med: 18.18 Max: 300.18
Current: 9.54
During the past 13 years, the highest EV-to-OCF of Nihon Kohden was 300.18. The lowest was -113.61. And the median was 18.18.
NHNKY's EV-to-OCF is ranked worse than 53.29% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 7.865
vs NHNKY: 9.54
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Nihon Kohden's PE Ratio (TTM) for today is calculated as:
Nihon Kohden's share price for today is $10.01.
Nihon Kohden's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.546.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Nihon Kohden EV-to-OCF Related Terms
Nihon Kohden EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Nihon Kohden's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Nihon Kohden's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nihon Kohden EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nihon Kohden's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Nihon Kohden's EV-to-OCF falls into.
Nihon Kohden's current Enterprise Value is $1,426 Mil.
Nihon Kohden's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $149 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nihon Kohden (NHNKY) has a EV-to-OCF of 9.58 as of Sep. 17, 2026. This is 47% below median its historical median of 18.18. According to the industry distribution chart, Nihon Kohden ranks #454 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 53.3%.
Is Nihon Kohden's EV-to-OCF too high?
Nihon Kohden's current EV-to-OCF of 9.58 is 47% below median its 10-year median of 18.18. The Medical Devices & Instruments industry median EV-to-OCF is 7.87. Nihon Kohden's value of 9.58 is 21.8% above this industry median. Based on the distribution chart, Nihon Kohden ranks #454 out of 852 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Nihon Kohden has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nihon Kohden's EV-to-OCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nihon Kohden ranks #454 out of 852 companies for EV-to-OCF. This places Nihon Kohden in the lower half of its industry. The industry median EV-to-OCF is 7.87. Nihon Kohden's value of 9.58 is 21.8% above this benchmark. While the company's 10-year median is 18.18 vs. the industry median of 7.87, Nihon Kohden has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.87, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nihon Kohden's current EV-to-OCF of 9.58 is 21.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nihon Kohden's current EV-to-OCF is 9.58, which is 47% below median its own 10-year median of 18.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nihon Kohden stock overvalued right now?
Based on GuruFocus' analysis, Nihon Kohden (NHNKY) is currently considered Modestly Undervalued. The stock's GF Value™ is $12.71, compared to a current price of $10.01 — trading 21.2% below its estimated fair value. The current EV-to-OCF is 9.58, which is 47% below median its 10-year median of 18.18 and 21.8% above the Medical Devices & Instruments industry median of 7.87. Nihon Kohden's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Nihon Kohden (NHNKY), the current EV-to-OCF is 9.58 as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nihon Kohden (NHNKY) Overvalued in 2026?
Based on GuruFocus' analysis, Nihon Kohden stock appears to be undervalued.
The current stock price of $10.01 is trading 21.2% below its estimated GF Value™ of $12.71.
GuruFocus considers Nihon Kohden to be Modestly Undervalued.
Key valuation signals for NHNKY:
EV-to-OCF: 9.58 (47% below median its 10-year median of 18.18)
GF Value™: $12.71 vs. price of $10.01 (21.2% below fair value)
Industry Position: 21.8% above the Medical Devices & Instruments median (#454 of 852)
No single metric tells the full story. See the NHNKY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nihon Kohden Corp is a Japan-based company engaged in the development, manufacturing, and sale of medical electronic equipment. It offers monitoring and diagnostic equipment such as electroencephalographs, electrocardiographs, and patient monitors, along with related systems and consumables. The company operates as a single business segment and manages its activities comprehensively across three reportable regions: Japan, North America, and Other Regions.
73GF Score
Get the complete analysis for NHNKY
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NHNKY has been successfully added to your 
